AC³T Participating Sites

Under the purview of AAI, BIO Ventures for Global Health (BVGH) launched the African Consortium for Cancer Clinical Trials (AC3T) to foster and implement cancer clinical trials led by investigators in Africa. AC3T is designed to build clinical trial capacity and address the cancer data gap in Africa, while increasing access to prioritized cancer diagnostics, medicines, and quality treatment for African cancer patients. AC3T will bring together AAI partners and key stakeholders to leverage cross-sector capabilities and empower African clinicians to implement cancer clinical trials in Africa.

To accomplish AC3T’s goals of building cancer clinical trial capacity, filling the cancer data gap in Africa, and increasing access to quality treatment and technologies, BVGH is profiling clinical trial sites in sub-Saharan Africa. Use the map below to see sites that are participating in AC3T. Scroll down this page to view sites’ profiles and in-depth information on their clinical trial capabilities.

AC³T Site Profiles

The interactive tool below displays in-depth information on AC3T participating sites’ clinical trials capabilities. Select a site from the Institution drop-down menu to see its profile. Note: ND stands for no data.

If you want your organization featured on the platform, please complete the AC3T checklist and email it to

For more information on the platform or the checklist, email

Our Partners

Driven by Africa – for Africa

To learn more about the African Access Initiative, contact Katy Graef